Floatz logo

Panobinostat

Pancreatic Adenocarcinoma

UNC Lineberger Comprehensive Cancer CenterSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
73/ 100

Competitive context

76 Active assets in the Pancreatic Adenocarcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Jonsson Comprehensive Cancer Center
Phase 4BBB
Irinotecan
Jonsson Comprehensive Cancer Center
Phase 3BB
Calcium folinate pentahydrate
Jonsson Comprehensive Cancer Center
Phase 4BB
Eloxatin
Jonsson Comprehensive Cancer Center
Phase 4BB
Capecitabine
Zhejiang University
Phase 4BB

View all 50 →

Same molecule, other indications

Panobinostat is also rated in:

Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Non-Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →